CEO Supply Chain Obstacles Podcast
In the ever changing arena of Healthcare supply chain companies cannot place too much emphasis on issues coming down the pipeline and how best to prepare for them.
LifeScience Logistics' CEO Richard Beney offers some expert insight into what he believes are upcoming issues companies can expect in this industry and advice on how best to combat these challenges.
Everest Biotech Case Study
How does a small biotech firm based in the UK and manufacturing in Nepal offer next day service to its U.S. client base?
Given the large initial size and rapid growth of the catalogue, it was also important to find a partner with sufficient storage capacity to accommodate future growth and an IT platform that could process a large number of SKUs quickly and accurately. By outsourcing U.S. distribution and store a complete inventory of catalogued products with LifeScience Logistics, Everest Biotech is able to offer next-day delivery to its U.S. customers, and its direct brand sales double in three months.
Supply Chain Visibility in Healthcare
Beyond the Dashboard
To support today’s business model in this high-velocity, complex and distributed logistics environment, real-time visibility has become a key strategic imperative. Visibility to suppliers’ production rates and shipment lead times, inhouse inventory, historical data, and customer sales projections can drive benefits in efficiency, lower inventories and improve fulfillment rates.
Keeping Your Cool
Life sciences 3PL gives customers greater supply chain control
LifeScience Logistics aims to offer a high-quality, nimble, and focused approach to supply chain management. The third-party logistics (3PL) provider serves pharmaceutical medical device, and biotech manufacturers, making warehouse temperature control of vital importance. To that end, the company offers a full range of environments, including frozen (-30˚C), refrigerated (2˚C–8˚C), and controlled ambient (20˚C–25˚C). Its services also are compliant with U.S. Food and Drug Administration (FDA) current Good Manufacturing Processes (cGMP), giving client’s further flexibility and control over their supply chains.